• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关于具有并联和串联结构器官的目标函数的研究。

A study of objective functions for organs with parallel and serial architecture.

作者信息

Stavrev P V, Stavreva N A, Round W H

机构信息

Department of Physics, University of Waikato, Hamilton, New Zealand.

出版信息

Australas Phys Eng Sci Med. 1997 Mar;20(1):4-10.

PMID:9141307
Abstract

An objective function analysis when target volumes are deliberately enlarged to account for tumour mobility and consecutive uncertainty in the tumour position in external beam radiotherapy has been carried out. The dose distribution inside the tumour is assumed to have logarithmic dependence on the tumour cell density which assures an iso-local tumour control probability. The normal tissue immediately surrounding the tumour is irradiated homogeneously at a dose level equal to the dose D(R) delivered at the edge of the tumour. The normal tissue in the high dose field is modelled as being organized in identical functional subunits (FSUs) composed of a relatively large number of cells. Two types of organs--having serial and parallel architecture are considered. Implicit averaging over intrapatient normal tissue radiosensitivity variations is done. A function describing the normal tissue survival probability S0 is constructed. The objective function is given as a product of the total tumour control probability (TCP) and the normal tissue survival probability S0. The values of the dose D(R) which result in a maximum of the objective function are obtained for different combinations of tumour and normal tissue parameters, such as tumour and normal tissue radiosensitivities, number of cells constituting a normal tissue functional unit, total number of normal cells under high dose (D(R)) exposure and functional reserve for organs having parallel architecture. The corresponding TCP and S0 values are computed and discussed.

摘要

针对外照射放疗中为考虑肿瘤移动性和肿瘤位置的连续不确定性而故意扩大靶区体积的情况,进行了目标函数分析。假设肿瘤内部的剂量分布与肿瘤细胞密度呈对数依赖关系,以确保肿瘤局部控制概率相同。紧邻肿瘤的正常组织以等于肿瘤边缘处剂量D(R)的剂量水平进行均匀照射。高剂量场中的正常组织被建模为由相对大量细胞组成的相同功能亚单位(FSU)。考虑了具有串联和平行结构的两种类型的器官。对患者体内正常组织放射敏感性变化进行了隐式平均。构建了描述正常组织存活概率S0的函数。目标函数表示为总肿瘤控制概率(TCP)与正常组织存活概率S0的乘积。针对肿瘤和正常组织参数的不同组合,如肿瘤和正常组织放射敏感性、构成正常组织功能单位的细胞数量、高剂量(D(R))照射下的正常细胞总数以及具有平行结构器官的功能储备,获得了使目标函数最大化的剂量D(R)值。计算并讨论了相应的TCP和S0值。

相似文献

1
A study of objective functions for organs with parallel and serial architecture.关于具有并联和串联结构器官的目标函数的研究。
Australas Phys Eng Sci Med. 1997 Mar;20(1):4-10.
2
The modelled benefits of individualizing radiotherapy patients' dose using cellular radiosensitivity assays with inherent variability.使用具有内在变异性的细胞放射敏感性测定法对放疗患者剂量进行个体化的模拟益处。
Radiother Oncol. 1999 Jan;50(1):67-75. doi: 10.1016/s0167-8140(98)00132-7.
3
A new method for optimum dose distribution determination taking tumour mobility into account.一种考虑肿瘤移动性的最佳剂量分布确定新方法。
Phys Med Biol. 1996 Sep;41(9):1679-89. doi: 10.1088/0031-9155/41/9/008.
4
Optimum parameters in a model for tumour control probability, including interpatient heterogeneity: evaluation of the log-normal distribution.包含患者间异质性的肿瘤控制概率模型中的最佳参数:对数正态分布评估
Phys Med Biol. 2007 Jan 7;52(1):291-302. doi: 10.1088/0031-9155/52/1/019. Epub 2006 Dec 20.
5
Probability of radiation-induced complications for normal tissues with parallel architecture subject to non-uniform irradiation.
Med Phys. 1993 May-Jun;20(3):613-25. doi: 10.1118/1.597056.
6
EUD-based radiotherapy treatment plan evaluation: incorporating physical and Monte Carlo statistical dose uncertainties.基于等效均匀剂量的放射治疗计划评估:纳入物理和蒙特卡罗统计剂量不确定性。
Phys Med Biol. 2005 Sep 7;50(17):4097-109. doi: 10.1088/0031-9155/50/17/013. Epub 2005 Aug 24.
7
Predicting the radiation control probability of heterogeneous tumour ensembles: data analysis and parameter estimation using a closed-form expression.预测异质性肿瘤集合体的放射控制概率:使用闭式表达式进行数据分析和参数估计
Phys Med Biol. 1998 Aug;43(8):2159-78. doi: 10.1088/0031-9155/43/8/012.
8
Microdosimetry and radiocurability: modelling targeted therapy with beta-emitters.
Phys Med Biol. 1996 Oct;41(10):1957-72. doi: 10.1088/0031-9155/41/10/008.
9
Are more complicated tumour control probability models better?更复杂的肿瘤控制概率模型会更好吗?
Math Med Biol. 2013 Mar;30(1):1-19. doi: 10.1093/imammb/dqr023. Epub 2011 Oct 17.
10
Computed 88% TCP dose for SBRT of NSCLC from tumour hypoxia modelling.计算非小细胞肺癌 SBRT 的肿瘤缺氧模型的 88% TCP 剂量。
Phys Med Biol. 2013 Jul 7;58(13):4611-20. doi: 10.1088/0031-9155/58/13/4611. Epub 2013 Jun 14.

引用本文的文献

1
Re-irradiation for recurrent glioma- the NCI experience in tumor control, OAR toxicity and proposal of a novel prognostic scoring system.复发性脑胶质瘤再放疗:NCI 在肿瘤控制、OAR 毒性方面的经验及新预后评分系统的提出。
Radiat Oncol. 2017 Nov 29;12(1):191. doi: 10.1186/s13014-017-0930-9.